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Abstract 
Background: The infectivity of Plasmodium gametocytes is typically determined by microscopically examining the 
midguts of mosquitoes that have taken a blood meal containing potentially infectious parasites. Such assessments 
are required for the development and evaluation of transmission-reducing interventions (TRI), but are limited by 
subjectivity, technical complexity and throughput. The detection of circumsporozoite protein (CSP) by enzyme-linked 
immunosorbent assay (ELISA) and enhanced chemiluminescent slot-blot (ECL-SB) may be used as objective, scalable 
alternatives to microscopy for the determination of infection prevalence.
Methods: To compare the performance of the CSP ELISA and ECL-SB for the detection of mosquito infection, four 
groups of Anopheles stephensi mosquitoes were infected with cultured Plasmodium falciparum gametocytes. At day-8 
post-infection (PI), parasite status was determined by microscopy for a sample of mosquitoes from each group. At 
days 8 and 10 PI, the parasite status of separate mosquito samples was analysed by both CSP ELISA and ECL-SB.
Results: When mosquito samples were analysed 8 days PI, the ECL-SB determined similar infection prevalence to 
microscopy; CSP ELISA lacked the sensitivity to detect CSP in all infected mosquitoes at this early time point. When 
mosquitoes were analysed 48 h later (10 days PI) both assays performed as well as microscopy for infection detection.
Conclusions: Whilst microscopical examination of mosquito guts is of great value when quantification of para-
site burden is required, ECL-SB and CSP ELISA are suitable alternatives at day 10 PI when infection prevalence is the 
desired endpoint, although CSP ELISA is not suitable at day 8 PI. These results are important to groups considering 
large-scale implementation of TRI.
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Background
Transmission-reducing interventions (TRIs) that spe-
cifically aim to interrupt the transmission of malaria 
from man to mosquito form important components 
of malaria control and elimination strategies [1, 2]. The 
development, targeting and evaluation of TRIs requires 
robust assessments of the infectivity of human malaria 
infections to mosquitoes [3, 4]. Mosquito infection sta-
tus is typically determined by microscopy following the 
observation of Plasmodium oocysts in the midgut or 
sporozoites in the salivary glands [5, 6]. Oocysts develop 
on the basal lamina of the mosquito midgut approxi-
mately 2 days after the ingestion of a blood meal contain-
ing infectious gametocytes, and can be visually detected 
by microscopy approximately 6  days post infection (PI) 
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[5]. Sporozoites develop from the budding of sporoblasts 
in the developing oocyst, which give rise to hundreds 
or thousands of sporozoites in an explosive population 
expansion that starts 7–8 days PI [7, 8]. Beyond 10 days 
PI, sporozoites rupture the oocyst capsule and enter the 
haemolymph, beginning their migration to the mos-
quito salivary glands [7, 9]. Within 8  h of their release, 
sporozoites must invade the salivary glands or else be 
broken down in the mosquito haemolymph [10]. Sporo-
zoites that succeed in entering the salivary glands are 
detectable from about 11 days PI, and the number in the 
glands appears to plateau after approximately 14 days PI 
[11] where they remain viable for long periods [12, 13]. 
Because of this stability and because very few sporozo-
ites are egested during blood feeding [14, 15] it is gener-
ally accepted that a mosquito with any number of salivary 
gland sporozoites is infective to humans.
The goal of TRIs is to reduce the proportion of mos-
quitoes becoming infectious after taking a blood meal 
on vaccinated or treated individuals [16]. A recent study 
showed that eventual infectivity can be predicted with 
reasonable certainty from the detection of maturing 
oocysts in low-intensity infections [11]. With highly 
trained technicians, mosquito dissections can be per-
formed quickly; however, the ability to properly identify 
and quantify developing oocysts is a specialized skill 
that requires long periods of training. Furthermore, the 
necessity to screen individual midguts during a lim-
ited time-window PI limits the throughput of mosquito 
feeding assays. It is highly desirable that the endpoint 
for efficacy assessments of TRIs be unambiguous, flex-
ible with regard to the timing of mosquito processing, 
and usable by non-specialized staff. Screening mos-
quitoes for oocyst stage infections by high throughput 
immunological or molecular tools may provide an alter-
native to microscopy for processing large volumes of 
mosquitoes.
Circumsporozoite protein (CSP) is a ~60  kD glyco-
sylphosphatidyl-inositol (GPI)-anchored sporozoite, 
surface-coat protein with roles in parasite development 
in oocysts [17], traversal of the haemocoel [18], recogni-
tion and binding to the salivary glands [19, 20], protec-
tion after egestion into the human microvasculature 
[18], and invasion of human hepatocytes [21, 22]. In the 
mosquito, CSP is abundantly expressed by the develop-
ing parasite [23], making the protein an ideal target for 
immuno-assays. The colorimetric enzyme-linked immu-
nosorbent assay (ELISA) is commonly used for the detec-
tion of Plasmodium CSP in wild-caught mosquitoes [6, 
24–26], where salivary gland infection (measured by 
homogenization of the head or head and thorax) has gen-
erally been the endpoint of interest. A positive ELISA 
test result indicates that mosquitoes ingested infectious 
parasites more than 11  days prior to assessment. If the 
ELISA is performed at 7 days PI, when oocysts are visible 
by microscopy, CSP expression by developing oocysts is 
too low for detection [11]. The enhanced chemi-lumines-
cent ELISA (ECL ELISA) and slot-blot assays (ECL-SB) 
were designed to overcome these issues of sensitivity, and 
are capable of detecting as little as 4.4 and 1 pg of recom-
binant CSP, respectively [27, 28], which could allow for 
Plasmodium detection shortly after the onset of CSP pro-
duction during oocyst development.
Here, two immunoassays, the CSP ELISA and ECL-SB, 
were evaluated for their ability to detect CSP in mosquito 
homogenates processed from whole mosquito carcasses, 
by comparison to mosquito samples analysed by standard 
dissection and oocyst enumeration. Gametocyte cultures 
were diluted to ensure parasite burden in test mosqui-
toes was close to the level of Plasmodium-infected vec-
tors from endemic regions [29, 30], providing groups of 
mosquitoes with controlled, but varying infection prev-
alence to investigate the performance of the two assays 
relative to microscopy for the detection of oocyst-stage 
infections. Since CSP expression increases during oocyst 
maturation [27, 31], the sensitivity of the assays in longer 
term infected mosquito specimens that contain a higher 
amount of CSP was also examined.
Methods
Infection of Anopheles stephensi mosquitoes 
with Plasmodium falciparum parasites
1. Mosquito rearing: Anopheles stephensi (Sind-Kasur 
Nijmegen strain) [32] were reared at 30  °C and 
70–80 % humidity, while exposed to a 12/12 h day/
night cycle.
2. Parasite culture: Mature Plasmodium falciparum 
(NF54) gametocytes (14-day culture, 0.3–0.5  % 
gametocytes, 2  % haematocrit) were obtained from 
an automated tipper system and prepared as previ-
ously described [33, 34]. To achieve low-intensity 
infections, infective blood meals that are routinely 
used and produce high infection prevalence (averag-
ing >70  % with mean oocyst intensities in infected 
mosquitoes >10) were diluted at a ratio of 1:10 with 
uninfected blood.
3. Mosquito feeding assays: Four separate batches 
of gametocyte material were each fed to multiple 
cages of mosquitoes (10 cages total). For each cage, 
approximately 150 three- to five-days old Anopheles 
stephensi mosquitoes were fed on a glass membrane 
midi-feeder system containing ~1.25 mL of the P. fal-
ciparum culture mix [33, 34]. Unfed and partially fed 
mosquitoes were removed after feeding and blood-
fed females were maintained at 26  °C and 70–80  % 
humidity.
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4. Experimental design: After infection, mosquitoes 
were combined to have four large batches of mosqui-
toes that allowed examination by microscopy, CSP 
ELISA and ECL-SB. At day 8 PI, 20–30 mosquitoes 
per batch were examined for oocysts by microscopy. 
At days 8 and 10 PI, 36–48 mosquitoes per batch 
were stored at −20  °C in sealed containers until 
analysis by CSP ELISA and ECL-SB. Sample sizes for 
the two assays were maximised based on the avail-
ability of live mosquitoes at the two time points and 
were kept uniform between the two assays. Left-over 
mosquitoes were killed and discarded. Full details of 
mosquito sample sizes for all assays and groups are in 
Table 1.
Microscopy
Routine staining of midguts for oocyst detection was 
done in 1 % mercurochrome, as described previously [11, 
33]. All oocyst detection was performed once by expert 
staff at Radboud UMC, Nijmegen, The Netherlands.
ECL slot‑blot
1. Preparation of whole mosquito homogenates: CSP 
expression on the developing oocysts was deter-
mined in lysed whole mosquitoes using a procedure 
described previously [27]. Briefly, individual blood-
fed or unfed mosquitoes were placed into single 
tubes and homogenized with a piston in 50 μl of lysis 
buffer (1× TBS, 0.5 % SDS). The lysates were subse-
quently vortexed for 20 s and then boiled for 5 min. 
The insoluble material was pelleted via centrifugation 
and the supernatant was collected and analysed.
2. mAb 2A10: Anti-Pf CSP mAb 2A10 was generated 
using a hybridoma cell line acquired from the MR4/
ATCC, Virginia, USA. A commercial source was 
used to produce ascites in mice and purify antibod-
ies by Protein G affinity chromatography (Harlan 
Laboratories Inc. Madison, WI, USA). mAb 2A10 
(1.55  mg/mL) immune-reactivity was characterized 
in IFA using P. falciparum sporozoites and in ELISA 
and Western Blot using rPf CSP.
3. Performance of the ECL-SB: This assay was performed 
using a Minifold 48 slots, Whatman apparatus (GE 
Healthcare Life Sciences, 10447941; Piscataway, NJ, 
USA) in a slightly modified version of the standard 
protocol [27]. The ECL-reagents used in this assay 
were purchased as a kit (Life Technologies, Western-
StarTM Immunodetection System, T1046, Grand 
Island, NY, USA). Approximately 20 µL of each sam-
ple lysate was loaded into each slot-blot well. Sample 
proteins were allowed to adsorb onto the nitrocellu-
lose membrane for 1  h and then slots were washed 
with 500 µL of deionized water four times. The mem-
brane was next blocked at room temperature (RT) in 
iBlock blocking buffer (Applied Biosystems, T2015, 
Foster City, CA, USA) for 1  h before being probed 
with anti-Pf CSP mAb 2A10 (at 0.31  µg/mL) for an 
additional hour. The membrane was subsequently 
washed three times (5 min each) in deionized water 
and three times in iBlock blocking buffer. After the 
washings, the membrane was incubated with an AP-
conjugated ECL-goat anti-mouse-IgM + IgG second-
ary antibody (1:5000 dilution) for 1 h at RT and then 
washed again as described following incubation with 
mAb 2A10. Before development, the membrane was 
rinsed twice for 2 min with 25 mL of 1× assay buffer 
and bands were visualized by incubating the mem-
brane in 6  mL of ECL-substrate solution at RT for 
5 min and exposure to an AR film (Kodak X-OMAT 
1000A).
4. ECL slot blot data acquisition and analysis: The band 
profile on the developed film was scanned and ana-
lysed using the ImageJ program [35]. The integrated 
optical density (IOD) of each band was determined 
by measuring the band intensity in a ‘gated area’. The 
dimensions of the gated area for IOD determina-
tion was kept constant for each band on the scanned 
image. The capacity of a single blot was 48 mosquito 
samples, including three to five negative controls 
for the calculation of CSP positivity. Each blot was 
developed separately. As there were large variations 
in IOD values between blots (Fig. 1), positivity deter-
mination for test mosquitoes was blot-specific, based 
on the mean IOD values of the negative controls pro-
cessed in each blot. As the total number of mosqui-
toes processed at each time point in groups 2 and 4 
exceeded the capacity of a single blot (48 test mos-
quitoes plus controls), a small number of test mos-
quitoes from these groups were processed in separate 
blots (8 and 5 mosquitoes from each time point for 
groups 2 and 4, respectively), the results of which are 
shown in Additional file 1: Figure S1. Cut-off values 
for the determination of positive and negative speci-
mens in each run of the experiment were determined 
as the mean plus two times the standard devia-
tion of the uninfected mosquito band intensities, as 
described previously [27].
ELISA
1. 3SP2 mAb: Anti-Pf CSP mAb 3SP2 was generated 
at Radboud UMC, Nijmegen, The Netherlands as 
described previously [14, 26].
2. CSP-ELISA: CSP ELISA was performed as previously 
described [11]. Mosquitoes were homogenized in 
250 μl phosphate buffered saline (PBS pH 7.2) solu-
tion with 1  % sarcosil. Sterilin ELISA plates were 
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Fig. 1 ECL-SB integrated optical density values for mosquito homogenate bands exposed by X-ray. The capacity of the slot blot apparatus was 48 
mosquito homogenates, including three to five negative controls for the calculation of CSP positivity. Each blot was developed separately, giving 
rise to the varied IOD values in the figure. Positivity determination was thus blot-specific, based on the mean IOD values of the negative controls 
obtained in each blot. As the total number of mosquitoes processed at each time point in groups 2 and 4 exceeded the capacity of a single blot (48 
test mosquitoes plus controls), a small number of test mosquitoes from these groups were processed in separate blots (eight and five mosquitoes 
from each time point for groups 2 and 4, respectively), the results of which are shown in Additional file 1: Figure S1. For clarity, the primary figure 
shows blots containing the majority of mosquitoes from all groups and time points
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coated with 3SP2 mAb at 5  µg/mL, diluted in PBS. 
Fifty microliters of mosquito homogenate from all 
test mosquitoes was analysed in duplicate (100  μl 
total), alongside blank wells (50  μl of sample dilu-
ent) and a standard curve of recombinant CSP (50 
µL Gennova, 0.1 µg/mL). A selection of homogenates 
from 15 uninfected blood-fed control mosquitoes 
were tested on every plate as a visual control, giving 
OD values between 0.06 and 0.08. OD values were 
adjusted for plate-to-plate variation by subtracting 
plate blank values. A universal cut-off for CSP posi-
tivity was determined at an optical density (OD) of 
0.311 using maximum likelihood methods to estab-
lish CSP-negative and CSP-positive Gaussian distri-
butions from the corrected OD values of all 336 test 
mosquitoes. The cut-off was set as the mean OD of 
the CSP-negative distribution plus three standard 
deviations, as previously described [36, 37].
Statistical analysis
Statistical significance between ECL Slot-blot and ELISA-
based prevalence estimates and those measured by 
microscopic detection after dissection of mosquito mid-
guts were evaluated using the Chi square test for homo-
geneity. Statistical analysis was conducted in GraphPad 
Prism 5.0 (GraphPad Software Inc, CA, USA), and con-
fidence intervals for prevalence estimates were generated 
using STATA 12 (StataCorp., TX, USA).
Results
Infection of Anopheles stephensi mosquitoes 
with Plasmodium falciparum gametocyte cultures
Mosquitoes were fed blood meals containing four 
batches of gametocytes from P. falciparum cultures 
diluted to generate varying infection rates (Table  1). 
Parasite burdens and overall infection prevalences were 
estimated after mosquito dissection and oocyst detec-
tion and counting by microscopy on a subset of 20–30 
randomly sampled mosquitoes from each group on day 8 
PI. Additional paired samples of 36–48 mosquitoes were 
then removed from each of the four groups on days 8 and 
10 PI for processing and assessment in the ECL-SB and 
ELISA (one sample for each day and method). The mos-
quitoes were randomly selected from the cages fed on the 
same gametocyte material by the same feeders. Since dif-
ferent mosquitoes were used for each of the three assays, 
some inherent variation in mosquito infection rates was 
expected. Full details of sample sizes in different test 
groups for all assays are in Table 1. In total, 104 test mos-
quitoes were analysed by microscopy on day 8 PI, 336 
test mosquitoes were analysed in the ECL-SB on days 8 
and 10 PI, and 336 test mosquitoes were analysed in the 
ELISA on days 8 and 10 PI.
Oocyst detection by microscopy
Mean oocyst intensities for groups 1 through 4 were 0.5, 
0.9, 6.1 and 7.7 (range 0–22), with corresponding oocyst 
prevalences of 20.8, 40, 70, and 93.3  %, respectively, 
when assessed on day 8 PI (Table 1). The percentages of 
infected mosquitoes with only a single oocyst were 0, 25, 
11 and 5 %, respectively for groups 1 through 4.
Prevalence estimation using ECL‑SB
Table  1 shows that at all oocyst intensities and time 
points the ECL-SB accurately estimated oocyst preva-
lence as detected by microscopy in mosquito samples 
from the same feed. All prevalence estimates were made 
using a cut-off threshold of two standard deviations from 
the mean of the IOD (integrated optical density) values 
obtained from ECL-SB from uninfected mosquitoes, as 
described previously [27]. Actual IOD values vary sig-
nificantly between separate assay repeats according to 
the relative time exposed to X-ray, but positive/negative 
determination was consistently robust within experi-
ments (Fig. 1).
Prevalence estimation using ELISA
In line with previous results [11], the ELISA was not suf-
ficiently sensitive to detect CSP present in infected mos-
quitoes at day 8 PI, regardless of oocyst intensity (Fig. 2). 
Fig. 2 ELISA OD values for all test and negative control mosquitoes. 
Plate-specific correction of OD values against background reactivity 
allowed for the calculation of a universal cut-off for positivity, which 
was determined statistically (OD 0.311, shown as the dotted line) [36, 
37, 43]. Data points are colored as in Fig. 1
Page 7 of 9Stone et al. Malar J  (2015) 14:451 
However, after an additional 48 h, the ELISA accurately 
estimated the microscopically determined oocyst preva-
lence at all oocyst intensities. No significant differences 
were observed between prevalence estimates made by 
ELISA and microscopy (Table  1; p  >  0.29), or between 
ELISA and ECL-SB compared directly (p ≥ 0.4) for mos-
quitoes analysed at day 10 PI.
Discussion
This study describes the ability of two immuno-assays, the 
CSP-ELISA and ECL-SB, to detect low-density mosquito-
stage P. falciparum infections based on the detection 
of CSP in the mosquito carcass. The results suggest that 
when mosquitoes are assayed 10  days after ingestion of 
an infective blood meal containing gametocytes, infection 
detection by the CSP-ELISA and ECL-SB provide preva-
lence estimates that are comparable to those obtained by 
microscopy. If mosquitoes are assayed earlier (8 days PI), 
only the ECL-SB has the sensitivity to accurately estimate 
true infection prevalence, as compared to microscopy.
The results of the current study corroborate recent 
data indicating that the ECL-SB can detect CSP shortly 
after its production begins in parallel to the budding out 
of sporozoites in midgut oocysts [31]. Marginally higher 
prevalence estimates at day 10 PI compared to day 8 PI in 
groups 2 and 3, which contained single oocyst infections 
(mean oocyst intensity 0.9–6.1) suggest that some slower 
developing oocysts in low-intensity infections may be 
missed if the assay is performed early. The challenges to 
detecting developing oocysts on day 8 PI was more pro-
nounced when the colorimetric ELISA was used [11]. A 
third method, the ECL-ELISA, was recently proposed as 
an enhancement of the standard colorimetric ELISA for 
the detection of CSP in whole homogenized mosquito 
samples [28]. This assay is capable of detecting an amount 
of CSP equivalent to that produced by 1.7 oocysts in mos-
quitoes processed at day 8 PI, a significant improvement 
on the colorimetric ELISA, although still possibly incapa-
ble of detecting single oocyst infections at this time point. 
Though the experiments were not powered to investigate 
the impact of oocyst intensity on assay sensitivity, the 
similar level of concordance with microscopy across the 
range of infection intensities we observed (1–22 oocysts) 
indicate that both ECL-SB and ELISA reliably detected 
single oocyst infections at day 10 PI; the ECL-SB also 
detecting the vast majority at day 8 PI. ECL-SB prevalence 
estimates were in fact most concordant with microscopy 
in mosquito groups with only 1–4 oocysts (1 and 2), 
including group 2 where 25 % of all infected mosquitoes 
sampled by microscopy harboured only a single oocyst. 
This indicates that the assays used would have great util-
ity for the detection oocysts in Plasmodium infected vec-
tors from endemic areas (e.g. mosquitoes infected during 
direct mosquito feeding assays), which are commonly in 
the 1–5 oocyst range [29, 38].
In the context of public health, the prevalence of mos-
quitoes that are infectious to humans is the most rele-
vant output for determining the efficacy of TRIs [16, 39]. 
Oocysts may produce many thousands of sporozoites, 
the majority capable of invading and establishing them-
selves in the salivary glands where they await egestion by 
the blood-feeding mosquito into the human dermis [12, 
13]. Since mosquitoes egest very few sporozoites when 
feeding, a mosquito with any number of sporozoites is 
probably infectious [14, 15].
While the presence of salivary gland sporozoites marks 
infectiousness to humans, detecting earlier developmen-
tal stages may have significant operational benefits. For 
mosquito-feeding experiments, storage time after feeding 
is a major concern as mosquito mortality may drastically 
limit sample size for analysis [11, 40, 41]. Early infection 
detection based on oocyst detection is reliable from day 
6 PI by microscopy and, although a minority of oocysts 
may fail to produce sporozoites [9, 11], reliably predicts 
later sporozoite salivary gland infection [11]. Oocysts are 
thereby detectable before sporozoite proliferation, how-
ever, the routine microscopical detection of oocysts has 
a subjective element and requires highly trained micros-
copists to reliably detect low-density infections. CSP-
based assays form an attractive alternative to microscopy 
because of CSP abundance, and specificity to the oocyst 
and sporozoite stages of sporogonic development [23]. 
Though CSP detection necessitates mosquito process-
ing at day 8 PI or later [11, 27, 28], the fact of its detec-
tion may be a more reliable predictor of actual mosquito 
infectivity than the observation of oocyst capsules or 
presence of parasite DNA. For the assays in the current 
study, requirements for mosquito processing are modest, 
and equipment and assay methods relatively low-tech.
One element that is consistent for ELISA, ECL-SB and 
other immunological approaches to infection detection 
in whole mosquito homogenates is the method of mos-
quito homogenization. This has the benefit that mosqui-
toes may be killed in their cages by removal to −20  °C 
freezers, then moved into sealed storage until analysis. 
Microscopy is constrained by strict scheduling based on 
the dates of experimental infections, whereas immuno-
logical and molecular assays may be separated from the 
schedule of feeding experiments at the convenience of 
the operator.
Another similarity between the ELISA and the ECL-
SB is the relative low cost and opportunities to increase 
throughput, which is beneficial for low-resource settings 
and for settings where the proportion of infected mos-
quitoes is low. For the assays performed in this study, 
the estimated cost per mosquito was 0.96 USD for the 
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ECL-SB and <0.1 USD for CSP ELISA. For the ECL-SB 
as performed here, 48 mosquitoes per apparatus can 
be assayed each day. For the ELISA, throughput is even 
higher and technology and equipment are routinely avail-
able in most research laboratories. For the CSP ELISA as 
performed here, 96 mosquitoes can be assayed per plate 
and ten plates can easily be processed by a single techni-
cian, with assays being completed in a 2-day period.
Conclusions
The results of this and previous studies indicate that 
either the ECL-SB or ELISA may replace microscopy for 
infection detection at day 10 PI, and that ECL-SB may do 
so 2 days earlier with no risk to assay sensitivity. Samples 
were not tested at day 9 PI, but it is possible the ELISA 
may have performed better at this time point. Availability 
of novel early midgut stage and trans-midgut stage, non-
CSP based biomarkers may further improve the sensitiv-
ity of immunological assays for Plasmodium detection 
in mosquitoes. Efforts to develop such assays for trans-
midgut stage (days 2–10 PI) Plasmodium detection are 
underway. The ECL-SB’s throughput is dependent on 
the number of apparatuses available, while the ELISA’s 
throughput is essentially only limited by the number of 
available technicians. The remaining bottleneck to the 
employment of either technique for tertiary evaluation 
of TRI is therefore mosquito processing [42]. A reliable 
method of high throughput mosquito homogenization 
involving minimal equipment costs will further enhance 
the scalability of the assays described here.
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